MML Investors Services LLC trimmed its position in MetLife, Inc. (NYSE:MET – Free Report) by 0.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 155,333 shares of the financial services provider’s stock after selling 691 shares during the quarter. MML Investors Services LLC’s holdings in MetLife were worth $12,812,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. MeadowBrook Investment Advisors LLC increased its position in shares of MetLife by 244.4% in the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after buying an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. lifted its holdings in shares of MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 186 shares in the last quarter. Wolff Wiese Magana LLC increased its stake in MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 277 shares in the last quarter. Peterson Financial Group Inc. acquired a new stake in MetLife during the 3rd quarter worth approximately $30,000. Finally, Fortitude Family Office LLC increased its position in shares of MetLife by 177.3% during the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after acquiring an additional 266 shares in the last quarter. Institutional investors own 89.81% of the company’s stock.
MetLife Stock Performance
Shares of MetLife stock opened at $81.77 on Wednesday. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The business has a 50-day moving average price of $83.78 and a two-hundred day moving average price of $77.13. MetLife, Inc. has a 1-year low of $64.17 and a 1-year high of $89.05. The company has a market cap of $56.62 billion, a P/E ratio of 16.49, a PEG ratio of 0.78 and a beta of 1.06.
MetLife Dividend Announcement
Analysts Set New Price Targets
Several equities analysts have recently weighed in on MET shares. Jefferies Financial Group raised their price target on shares of MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a research note on Friday, September 27th. StockNews.com upgraded MetLife from a “hold” rating to a “buy” rating in a research note on Monday, November 25th. Morgan Stanley decreased their target price on MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research report on Monday, August 19th. Barclays decreased their target price on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a research report on Thursday, October 31st. Finally, Wells Fargo & Company increased their price target on MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Fourteen analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $88.62.
Read Our Latest Analysis on MetLife
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- Using the MarketBeat Stock Split Calculator
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- Are Penny Stocks a Good Fit for Your Portfolio?
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- Learn Technical Analysis Skills to Master the Stock Market
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.